AdvanBio develops and provides Autobio/BioYuan quality controls for diagnostic tests, ensuring accuracy and precision in medical laboratory technology. This offering enhances patient care by improving the reliability of diagnostic results through advanced bioanalysis and assay validation methods.
Funding
Funding not disclosed
Founders
Product
Problem
Diagnostic tests in medical laboratories require accurate and precise quality controls to ensure reliable results. Inconsistent or unreliable quality controls can lead to inaccurate diagnoses and potentially compromise patient care.
Solution
AdvanBio provides Autobio/BioYuan quality controls designed to ensure the accuracy and precision of diagnostic tests in medical laboratories. These quality controls utilize advanced bioanalysis and assay validation methods to improve the reliability of diagnostic results. By integrating emerging technologies with a deep understanding of biological materials, AdvanBio delivers solutions targeted at improving patient diagnosis through precision medicine. The company offers services including bioanalysis, assay development and validation, and regulatory consultation to support the healthcare community.
Target Audience
AdvanBio's primary customers are medical laboratories and diagnostic test manufacturers seeking to ensure the accuracy and reliability of their diagnostic testing processes.
Features
- Autobio/BioYuan quality controls for diagnostic tests
- Bioanalytical testing and quantitative analysis of biological molecules
- Assay development and validation services
- Regulatory consultation services to navigate global regulatory landscapes
- Focus on identifying clinical biomarkers for precision medicine
- Technical support for IVD and molecular diagnostics assays